To validate these findings, we performed immunohistochemistry and multiple immunofluorescence staining for CD8 and CCL17 on tumor sections from the initial mouse group (Figure 6A-C, 3G, Supplementary Figure S6B). The gene discussed is CD8A; the disease is neoplasm.